Prof. Dr. İSMAİL ÇELİK

Yayın Ağı

Makaleler 78

1. Phenotypic and Genetic Features that Differ Between Hereditary and Sporadic Melanoma: Results of a Preliminary Study from a Single Center from Turkey.

Cakir A., Elcin G., Kilickap S., Gököz Ö., Taskiran Z. E., Celik İ.

Dermatology practical & conceptual , cilt.13, sa.3, 2023 (SCI-Expanded, Scopus)

2. Smoker Relatives of Inpatients: A Reasonable but Heterogeneous Target Population for Smoking Cessation Program

AKTAŞ B. Y., HÜSEYİN B., YÜCE D., DİZDAR Ö., ERMAN M., HAYRAN M., et al.

Archives of Basic and Clinical Research , cilt.5, sa.1, ss.178-184, 2023 (TRDizin)

3. Immunogenicity and safety of the CoronaVac vaccine in patients with cancer receiving active systemic therapy

Karacin C., Eren T., Zeynelgil E., Imamoglu G. I., Altinbas M., Karadag I., et al.

FUTURE ONCOLOGY , cilt.17, ss.4447-4456, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

4. Clinical features and outcomes of COVID-19 in patients with solid tumors: Turkish National Registry Data

Ozdemir N., DİZDAR Ö., YAZICI O., AKSOY S., Dede D. S., Budakoglu B., et al.

INTERNATIONAL JOURNAL OF CANCER , cilt.148, sa.10, ss.2407-2415, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. Metastatic cutaneous melanoma epidemiological registry in Turkey: A preliminary evaluation of diagnosis and treatment approaches

Karaca B. S., Sezer A., Goksu S. S., ÇİÇİN İ., Erdem D., ÇUBUKÇU E., et al.

JOURNAL OF TRANSLATIONAL MEDICINE , cilt.19, 2021 (SCI-Expanded, Scopus)

6. Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study

Yasar H. A., Turna H., Esin E., Sedef A. M., Alkan A., Oksuzoglu B., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.26, sa.2, ss.267-272, 2020 (SCI-Expanded, Scopus)

7. Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study

ÜRÜN Y., Yasar H. A., TURNA Z. H., Esin E., Sedef A. M., Alkan A., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.25, sa.7, ss.1658-1664, 2019 (SCI-Expanded, Scopus)

8. The role of ABO blood groups in glial neoplasms

Alkan A., YAZICI G., CENGİZ M., Karakas Y., ÇELİK İ., Kars A., et al.

BRITISH JOURNAL OF NEUROSURGERY , cilt.33, sa.1, ss.43-46, 2019 (SCI-Expanded, Scopus)

9. TRANSCULTURAL ADAPTATION OF EORTC-QLQ-CR29 SCALE INTO TURKISH, AND ASSESSMENT OF VALIDITY AND RELIABILITY IN TURKISH PATIENTS WITH COLORECTAL CANCER

HAYRAN K. M., Yuce D., Kilickap S., Huseyin B., Erman M., Dizdar O., et al.

VALUE IN HEALTH , cilt.21, 2018 (SCI-Expanded, SSCI, Scopus)

10. EFFECTS OF CANCER TYPES ON LOCAL AND OUT-OF-CITY ADMISSIONS FOR MEDICAL CARE

HAYRAN K. M., Yuce D., Kilickap S., Dizdar O., Huseyin B., Erman M., et al.

VALUE IN HEALTH , cilt.21, 2018 (SCI-Expanded, SSCI, Scopus)

11. BİR SİGARA BIRAKMA POLİKLİNİĞİNDE UYGULANAN PSİKOEĞİTİMSEL SİGARA BIRAKMA POROGRAMININ ETKİNLİĞİ

KAMIŞLI S., YÜCE D., küçükçoban ş., HAYRAN K. M., KILIÇKAP S., ÇELİK İ., et al.

Anadolu Hemşirelik ve Sağlık Bilimleri Dergisi , cilt.20, sa.4, ss.234-242, 2017 (TRDizin)

12. Reinforcement of mental health in an interaction group of cancer patients

HAYRAN K. M., Kamisli S., Kucukcoban S., ÇELİK İ., KILIÇKAP S., YÜCE D.

PSYCHO-ONCOLOGY , cilt.26, ss.161, 2017 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma

13. Beneficiation routes for upgrading iron ore tailings with a teetered bed separator

ÖZCAN Ö., ÇELİK İ.

SEPARATION SCIENCE AND TECHNOLOGY , cilt.51, sa.17, ss.2844-2855, 2016 (SCI-Expanded, Scopus)

14. A Retrospective Study of 137 Dysplastic Nevi Are a Personal History of Melanoma and Histopathological Factors Associated with High grade Cytologic Atypia

DUMAN N., ERKİN G., GÖKÖZ Ö., KARAHAN S., KAYIKÇIOĞLU A. U., ÇELİK İ.

Journal of Cancer and Tumor International , cilt.2, sa.3, ss.110-116, 2015 (Hakemli Dergi)

15. Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish Study

Abali H., ÇELİK İ., Karaca B., TURNA Z. H., Saglam E. K., Akman T., et al.

JOURNAL OF BUON , cilt.20, sa.4, ss.1137-1141, 2015 (SCI-Expanded, Scopus)

16. QUALITY OF LIFE DOMAINS ASSOCIATED WITH READMISSION

HAYRAN K. M., YÜCE D., Huseyin B., Esin E., KILIÇKAP S., ERMAN M., et al.

VALUE IN HEALTH , cilt.18, sa.3, 2015 (SCI-Expanded, SSCI, Scopus)

17. Improved Anti-Emetic Efficacy of 5-HT3 Receptor Antagonists in Cancer Patients with Genetic Polymorphisms of ABCB1 (MDR1) Drug Transporter

Zoto T., KILIÇKAP S., YAŞAR Ü., ÇELİK İ., BOZKURT A., BABAOĞLU M. Ö.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY , cilt.116, sa.4, ss.354-360, 2015 (SCI-Expanded, Scopus)

18. Nationwide Smoking Cessation Treatment Support Program - Turkey project

ÇELİK İ., YÜCE D., Hayran M., ERMAN M., KILIÇKAP S., BUZĞAN T., et al.

HEALTH POLICY , cilt.119, sa.1, ss.50-56, 2015 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma

19. Nevus-Associated versus de novo Melanoma: Do They Have Different Characteristics and Prognoses?

Duman N., Erkin G., GÖKÖZ Ö., KARAHAN S., Kayikcioglu A. U., ÇELİK İ.

DERMATOPATHOLOGY , cilt.2, sa.1, ss.46-51, 2015 (ESCI)

20. HEALTH RELATED QUALITY OF LIFE IN CANCER PATIENTS: EVALUATION WITH A SELF-ADMINISTERED IPAD APPLICATION

YÜCE D., HAYRAN K. M., KILIÇKAP S., ERMAN M., ÇELİK İ.

VALUE IN HEALTH , cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus)

21. ASSOCIATION OF HEALTH CARE COST WITH QUALITY OF LIFE FOR VARIOUS TYPES OF CANCERS

HAYRAN K. M., YÜCE D., Huseyin B., Esin E., KILIÇKAP S., ERMAN M., et al.

VALUE IN HEALTH , cilt.17, sa.7, 2014 (SCI-Expanded, SSCI, Scopus)

22. Study of interaction with a group of cancer patients: guiding cancer patients through psychoeducational interventions

Kamisli S., HAYRAN K. M., Kucukcoban S., KILIÇKAP S., YÜCE D., ÇELİK İ.

EUROPEAN JOURNAL OF ONCOLOGY NURSING , cilt.18, 2014 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma

23. A Rare Variant of Melanoma Clinical Histopathological and Prognostic Features in 5 Cases of Animal Type Melanoma

DUMAN N., ERKİN G., GÖKÖZ Ö., KAYIKÇIOĞLU A. U., ÇELİK İ.

ACTA ONCOLOGICA TURCICA , cilt.47, sa.3, ss.20-25, 2014 (Hakemli Dergi)

24. Increasing performance of a hospital-based cancer registry: Hacettepe University hospitals experience

Kutluk T., HAYRAN K. M., Kilickap S., Yuce D., Celik I., Erman M., et al.

JOURNAL OF BUON , cilt.18, sa.4, ss.1088-1096, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

25. Mass Balance and Quantitative Mineralogy Studies for Circuit Modification

CAN N. M., ÇELİK İ., Bıçak Ö., Altun O.

MINERAL PROCESSING AND EXTRACTIVE METALLURGY REVIEW , cilt.34, sa.5, ss.348-365, 2013 (SCI-Expanded, Scopus)

26. Multicentric Ipilimumab Experience in Turkish Patients with Metastatic Melanoma: MIPI-TURK at 3 years

Sevinc A., TURNA Z. H., Ozdogan M., Buyukberber S., Demir G., Gokmen E., et al.

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT , cilt.11, ss.68-69, 2013 (SCI-Expanded, Scopus)

27. Clinical Features and Prognostic Factors of Hodgkin's Lymphoma: A Single Center Experience

KILIÇKAP S., BARIŞTA İ., ÜLGER Ş., ÇELİK İ., SELEK U., YILDIZ F., et al.

BALKAN MEDICAL JOURNAL , cilt.30, sa.2, ss.178-185, 2013 (SCI-Expanded, Scopus, TRDizin)

28. Bilateral Seqential Acral Lentiginous Melanoma of the Sole

Keskin O., ÇELİK İ., KARS S. A.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , cilt.23, sa.4, ss.276-277, 2013 (SCI-Expanded, Scopus, TRDizin)

29. Long-term complications in Hodgkin's lymphoma survivors

KILIÇKAP S., BARIŞTA İ., Ulger S., ÇELİK İ., SELEK U., Gullu I., et al.

TUMORI , cilt.98, sa.5, ss.601-606, 2012 (SCI-Expanded, Scopus)

30. Multimodality Treatment in the Management of Anorectal Melanoma: A Case Report and Review of the Literature

Tapan U., DİZDAR Ö., Bulut N., ÇELİK İ.

EURASIAN JOURNAL OF MEDICINE , cilt.43, sa.3, ss.189-191, 2011 (ESCI, TRDizin)

31. Frequency of comorbid illnesses in cancer patients in Turkey

Abali H., Ata A., Ozdogan M., Turhal S., Cabuk D., Seyrek E., et al.

JOURNAL OF BUON , cilt.16, sa.3, ss.557-560, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

32. Influence of Process Mineralogy on Improving Metallurgical Performance of a Flotation Plant

ÇELİK İ., CAN N. M., Sherazadishvili J.

MINERAL PROCESSING AND EXTRACTIVE METALLURGY REVIEW , cilt.32, sa.1, ss.30-46, 2011 (SCI-Expanded, Scopus)

33. FREQUENCY OF CANCER TYPES IN PATIENTS AGED 65 AND OLDER: RESULTS FROM CANCER REGISTRY DATABASE OF HACETTEPE UNIVERSITY HOSPITALS

Arslan C., KILIÇKAP S., Dede D. S., HAYRAN K. M., ERMAN M., ÇELİK İ., et al.

TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI , cilt.14, sa.3, ss.187-192, 2011 (SCI-Expanded, SSCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

34. Arsenic in drinking water and lung cancer: A systematic review

ÇELİK İ., Gallicchio L., Boyd K., Lam T. K., Matanoski G., Tao X., et al.

ENVIRONMENTAL RESEARCH , cilt.108, sa.1, ss.48-55, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

35. Prognostic impact of bone turnover markers in multiple myeloma

Dizdar O., Barista I., Kalyoncu U., Karadag O., Celik I., Kars A., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.26, sa.15, 2008 (SCI-Expanded, Scopus)

36. Erectile dysfunction in successfully treated lymphoma patients

AKSOY S., HARPUTLUOĞLU H., KILIÇKAP S., DİNÇER M., DİZDAR Ö., AKDOĞAN B., et al.

SUPPORTIVE CARE IN CANCER , cilt.16, sa.3, ss.291-297, 2008 (SCI-Expanded, Scopus)

37. Lower bone mineral density in geriatric patients with monoclonal gammopathy of undetermined significance

Dizdar O., Erman M., Cankurtaran M., Halil M., Ulger Z., Yavuz B. B., et al.

ANNALS OF HEMATOLOGY , cilt.87, sa.1, ss.57-60, 2008 (SCI-Expanded, Scopus)

38. Cancer in first-degree relatives: A cross-sectional study at a Turkish University

Hayran M., Senan S., Sengelen M., Erman M., Celik İ.

PSYCHO-ONCOLOGY , cilt.16, sa.3, 2007 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma

39. Biochemical markers of bone turnover in diagnosis of myeloma bone disease

Dizdar O., Barista I., Kalyoncu U., Karadag O., Hascelik G., Cila A., et al.

AMERICAN JOURNAL OF HEMATOLOGY , cilt.82, sa.3, ss.185-191, 2007 (SCI-Expanded, Scopus)

40. Tropisetron, ondansetron, and granisetron for control of chemotherapy-induced emesis in Turkish cancer patients: A comparison of efficacy, side-effect profile, and cost

Abali H., Celik I.

CANCER INVESTIGATION , cilt.25, sa.3, ss.135-139, 2007 (SCI-Expanded, Scopus)

41. L-2-hydroxyglutaric aciduria and brain tumors: Report of two patients with medulloblastoma and glioblastoma

Haliloglu G., Celik I., Karli O. K., Anlar B., Ozisik P., Akalan N., et al.

JOURNAL OF INHERITED METABOLIC DISEASE , cilt.29, ss.53, 2006 (SCI-Expanded, Scopus)

42. Acrocyanosis as a presenting symptom of Hodgkin lymphoma

Solak Y., Aksoy S., Kilickap S., Celik I.

AMERICAN JOURNAL OF HEMATOLOGY , cilt.81, sa.2, ss.151-152, 2006 (SCI-Expanded, Scopus)

43. Association of the ABCB1 3435C > T polymorphism with antiemetic efficacy of 5-hydroxytryptamine type 3 antagonists

Babaoglu M., Bayar B., Aynacioglu A., Kerb R., Abali H., Celik I., et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS , cilt.78, sa.6, ss.619-626, 2005 (SCI-Expanded, Scopus)

44. Expression of Fas and Fas-ligand and analysis of argyrophilic nucleolar organizer regions in squamous cell carcinoma: relationships with tumor stage and grade, and apoptosis

Guler N., Uckan S., Celik I., Oznurlu Y., Uckan D.

INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY , cilt.34, sa.8, ss.900-906, 2005 (SCI-Expanded, Scopus)

45. cTnT can be a useful marker for early detection of anthracycline cardiotoxicity

Kilickap S., Baristal I., Akgul E., Aytemir K., Aksoyek S., Aksoy S., et al.

ANNALS OF ONCOLOGY , cilt.16, sa.5, ss.798-804, 2005 (SCI-Expanded, Scopus)

46. Cytarabine-induced fever complicating the clinical course of leukemia

GÖNEN C., Celik I., Cetinkaya Y., Haznedaroglu I.

ANTI-CANCER DRUGS , cilt.16, sa.1, ss.59-62, 2005 (SCI-Expanded, Scopus)

47. CA 19-9 measurement as a screening: Higher cost, lower survival

Kilickap S., Abali H., Aksoy S., Celik I.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY , cilt.19, sa.12, ss.1428, 2004 (SCI-Expanded, Scopus)

48. Tamoxifen-induced tissue factor pathway inhibitor reduction: a clue for an acquired thrombophilic state?

Erman M., Abali H., ORAN B., Haznedaroglu I., Canpinar H., KİRAZLI Ş., et al.

ANNALS OF ONCOLOGY , cilt.15, sa.11, ss.1622-1626, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

49. Isolated hyperbilirubinemia following standard dose cytosine arabinoside in a patient with relapsed acute myeloid leukemia

Altundag O., Altundag K., Celik I., Turker A., Kars A.

AMERICAN JOURNAL OF HEMATOLOGY , cilt.75, sa.4, ss.263-264, 2004 (SCI-Expanded, Scopus)

50. Plasminogen activator inhibitor-1 as a link between pathological fibrinolysis and arthritis of Behcet's disease

Ozturk M., Ertenli I., Kiraz S., Haznedaroglu I., Celik I., Kirazli S., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.24, sa.2, ss.98-102, 2004 (SCI-Expanded, Scopus)

51. Analysis of menstrual, reproductive, and life-style factors for breast cancer risk in Turkish women - A case-control study

ORAN B., Celik I., Erman M., BALTALI E., ZENGİN N., Demirkazik F., et al.

MEDICAL ONCOLOGY , cilt.21, sa.1, ss.31-39, 2004 (SCI-Expanded, Scopus)

52. Biweekly irinotecan plus bolus 5-fluorouracil and folinic acid in patients with advanced stage colorectal cancer

Yalcin S., Oksuzoglu B., Tekuzman G., Engin H., Celik I., Turker A., et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY , cilt.33, sa.11, ss.580-583, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

53. The efficacy of oral cyclophosphamide plus prednisolone in early diffuse systemic sclerosis

Calguneri M., Apras S., Ozbalkan Z., Ertenli I., Kiraz S., Ozturk M., et al.

CLINICAL RHEUMATOLOGY , cilt.22, ss.289-294, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

54. Bevacizumab, bleeding, thrombosis, and warfarin

Kilickap S., Abali H., Celik I.

JOURNAL OF CLINICAL ONCOLOGY , cilt.21, sa.18, ss.3542, 2003 (SCI-Expanded, Scopus)

55. Pathologic thrombopoiesis of rheumatoid arthritis

Ertenli I., Kiraz S., Ozturk M., Haznedaroglu I., Celik I., Calguneri M.

RHEUMATOLOGY INTERNATIONAL , cilt.23, sa.2, ss.49-60, 2003 (SCI-Expanded, Scopus)

56. Weekly irinotecan in patients with metastatic colorectal cancer failing 5-fluorouracil-based chemotherapy: Efficacy and prognostic factors

Karaoglu A., Yalcin S., Tekuzman G., Kars A., Celik I., Guler N., et al.

TUMORI , cilt.89, sa.2, ss.141-145, 2003 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

57. Increased soluble FAS suggests delayed apoptosis in familial Mediterranean fever complicated with amyloidosis

Kiraz S., Ertenli I., Ozturk M., Haznedaroglu I., Calguneri M., Atalar E., et al.

JOURNAL OF RHEUMATOLOGY , cilt.30, sa.2, ss.313-315, 2003 (SCI-Expanded, Scopus)

58. High incidence of central nervous system involvement in patients with breast cancer treated with epirubicin and docetaxel

Abali H., Celik I.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , cilt.25, sa.6, ss.632-633, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

59. Modified ESHAP as salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma: Results of a single-center study of 32 patients

Ozturk M., Barista I., Altundag M., Turker A., Yalcin S., Celik I., et al.

CHEMOTHERAPY , cilt.48, sa.5, ss.252-258, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

60. Neoadjuvant chemotherapy with taxotere-epirubicin-5-fluorouracil (TEF) in local-regionally advanced breast cancer: A preliminary report

Baltahi E., Altundag M., Onat D., Abbasoglu O., Ozisik Y., Guler N., et al.

TUMORI J , cilt.88, sa.6, ss.474-477, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

61. Bloodstream thrombopoietin in rheumatoid arthritis with thrombocytosis

Kiraz S., Ertenli I., Ozturk M., Haznedaroglu I., Celik I., Kirazli S., et al.

CLINICAL RHEUMATOLOGY , cilt.21, sa.6, ss.453-456, 2002 (SCI-Expanded, Scopus)

62. Treatment of classical Kaposi's sarcoma with visceral involvement by weekly paclitaxel

Engin H., Celik I.

CLINICAL ONCOLOGY , cilt.14, sa.2, ss.178, 2002 (SCI-Expanded, Scopus)

63. 5,7,7,8,10-Pentabromo-7,8-dihydrobenzocyclooctene

Çelik I., Tutar A., Akkurt M., Özcan Y., Çakmak O.

ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS , 2002 (SCI-Expanded) Sürdürülebilir Kalkınma

64. Pineal germ cell tumor metastasis via ventriculoperitoneal shunt

Altundag O., Celik I., Kars A.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , cilt.25, sa.1, ss.104-105, 2002 (SCI-Expanded, Scopus)

65. Central nervous system bleeding as a first manifestation of immunothrombocytopenic purpura in Hodgkin's disease

Engin H., Abali H., Erman M., Karaoglu A., Celik I., Guler N.

HAEMATOLOGIA , cilt.31, sa.4, ss.373-375, 2002 (SCI-Expanded, Scopus)

66. Pathological haemostasis and 'prothrombotic state' in Behcet's disease

Kiraz S., Ertenli I., Ozturk M., Haznedaroglu I., Celik I., Calguneri M.

THROMBOSIS RESEARCH , cilt.105, sa.2, ss.125-133, 2002 (SCI-Expanded, Scopus)

67. Dihydropyrimidine dehydrogenase enzyme deficiency: Clinical and genetic assessment of prevalence in Turkish cancer patients

Celik I., Kars A., Guc D., Tekuzman G., Ruacan S.

CANCER INVESTIGATION , cilt.20, sa.3, ss.333-339, 2002 (SCI-Expanded, Scopus)

68. 2,2-exo-3,5,6-Pentabromobicycloheptane

Hokelek T., Celik I., TUTAR A., CAKMAK O.

ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE , cilt.57, 2001 (SCI-Expanded)

69. Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy

Barista I., Tekuzman G., Yalcin S., Gullu I., Guler N., Ozisik Y., et al.

JOURNAL OF SURGICAL ONCOLOGY , cilt.73, sa.1, ss.12-16, 2000 (SCI-Expanded, Scopus)

70. Crystal structure of 2,2-exo-3,5,5-exo-6-hexabromobicycloheptane, C7H6Br6

Akkurt M., Celik I., Tutar A., Cakmak O., Ide S.

ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES , cilt.215, sa.4, ss.529-530, 2000 (SCI-Expanded, Scopus)

71. Crystal structure of 7-acetyl-5-benzoyl-6-phenyl-8-methyl-4,7-dihydropyrazolo[1,5-c]-1 H-pyrimidine-2-one

Celik I., Akkurt M., Ide S., Onal Z., Altural B.

ZEITSCHRIFT FUR KRISTALLOGRAPHIE , cilt.215, sa.1, ss.48-51, 2000 (SCI-Expanded)

72. Effects of colchicine on inflammatory cytokines and selectins in familial Mediterranean fever

KİRAZ S., ERTENLİ A. İ., ARICI M., Calguneri M., HAZNEDAROĞLU İ. C., ÇELİK İ., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.16, sa.6, ss.721-724, 1998 (SCI-Expanded, Scopus)

73. Phase II trial of MINE as a front-line therapeutic modality in intermediate- and high-grade non-Hodgkin's lymphomas

Celik İ., Kars A., Guler N., Barista I., Tekuzman G., Ozyilkan O., et al.

EUROPEAN JOURNAL OF CANCER , cilt.34, sa.5, ss.759-760, 1998 (SCI-Expanded, Scopus)

74. Maintenance therapy with alpha-interferon following first-line VAD in multiple myeloma

Kars A., Celik İ., Kansu E., Tekuzman G., Ozisik Y., Guler N., et al.

EUROPEAN JOURNAL OF HAEMATOLOGY , cilt.59, sa.2, ss.100-104, 1997 (SCI-Expanded, Scopus)

75. Timing of therapy in vasculitis-associated multiple myeloma: comment on the article by Hasegawa et al.

Topeli A., Barişta I., Celik İ., Kansu E.

Arthritis and rheumatism , cilt.40, ss.395-6, 1997 (SCI-Expanded, Scopus)

76. Agranulocytosis, plasmacytosis, and thrombocytosis followed by a leukemoid reaction due to acute acetaminophen toxicity

Gursoy M., Haznedaroglu I., Celik İ., Sayinalp N., Ozcebe O., Dundar S.

ANNALS OF PHARMACOTHERAPY , cilt.30, ss.762-765, 1996 (SCI-Expanded, Scopus)

77. Local fibrinolysis in native arteriovenous fistulas of haemodialysis patients

Haznedaroglu I., Erdem Y., Celik İ., Sayinalp N., Dundar S., Caglar S., et al.

BLOOD PURIFICATION , cilt.14, sa.3, ss.227-233, 1996 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

78. Serum levels of interleukin 6 and tumor necrosis factor-alpha in hyperthyroid patients before and after propylthiouracil treatment.

Celik İ., Akalin S., Erbaş T.

European journal of endocrinology , cilt.132, sa.6, ss.668-72, 1995 (Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 29

1. HACETTEPE’DE MELANOM TANISI ALAN HASTALARIN DEĞERLENDİRİLMESİ: 321 HASTAYA AİT RETROSPEKTİF TANIMLAYICI ÇALIŞMA

AKDOĞAN N., ELÇİN G., GÖKÖZ Ö., KONAŞ E., KILIÇKAP S., ÇELİK İ.

8. Ulusal Dermatolojik Cerrahi Günleri, Ankara, Türkiye, 18 Kasım 2021, (Özet Bildiri)

2. BİR ÜNİVERSİTENİN SİGARA BIRAKMA ÜNİTESİNE BAŞVURANLARIN ÖZELLİKLERİ VE SİGARA BIRAKMA OLASILIKLARI

ŞENGELEN M., ÇELİK İ., ERMAN M., Tezcan S., YÜCE D., Kamışlı S., et al.

2. ULUSLARARASI 20. ULUSAL HALK SAĞLIĞI KONGRESİ, Antalya, Türkiye, 13 - 17 Kasım 2018, (Özet Bildiri)

3. EFFECTS OF CANCER TYPES ON LOCAL AND OUT-OF-CITY ADMISSIONS FOR MEDICAL CARE

HAYRAN K. M., YÜCE D., KILIÇKAP S., DİZDAR Ö., houssein b., ERMAN M., et al.

ISPOR Asia Pacific 2018, Tokyo, Japonya, 8 - 11 Kasım 2018, (Özet Bildiri) Sürdürülebilir Kalkınma

4. TRANSCULTURAL ADAPTATION OF EORTC-QLQ-CR29 SCALE INTO TURKISH, AND ASSESSMENT OF VALIDITY ANDRELIABILITY IN TURKISH PATIENTS WITH COLORECTAL CANCER

HAYRAN K. M., YÜCE D., KILIÇKAP S., houssein b., ERMAN M., DİZDAR Ö., et al.

ISPOR Asia Pacific 2018, Tokyo, Japonya, 8 - 11 Kasım 2018, cilt.1, ss.11, (Tam Metin Bildiri)

5. Metastatic Choroidal Melanoma: Single Center Experience

AKTAŞ B. Y., GÜNER G., DEMİR M., GÜVEN D. C., AKTEPE O. H., BÖLEK E. Ç., et al.

2. Ulusal İmmunoterapi ve Onkoloji Kongresi, Antalya, Türkiye, 31 Ekim - 04 Kasım 2018, ss.1-48, (Tam Metin Bildiri)

6. Reinforcement of mental health in an interaction group of cancer patients

HAYRAN K. M., Kamışlı S., küçükçoban ş., ÇELİK İ., KILIÇKAP S., YÜCE D.

2017 World Congress of Psycho-Oncology, 14 - 18 Ağustos 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

7. Efficiency of a psychoeducational Intervention for smoking cessation in a specialized cessation clinic

YÜCE D., KAMIŞLI S., KÜÇÜKÇOBAN ş., HAYRAN K. M., KILIÇKAP S., ÇELİK İ., et al.

2017 World Congress of Psycho-Oncology, 14 - 18 Ağustos 2017, (Özet Bildiri)

8. Smoker relatives of inpatients: A reasonable but heterogeneous target population for smoking cessation program

AKTAŞ B. Y., HOUSSEİN b., YÜCE D., DİZDAR Ö., KILIÇKAP S., ERMAN M., et al.

7th ECTOH Conference on Tobacco or Health, Porto, Portekiz, 22 - 25 Mart 2017, (Özet Bildiri) Sürdürülebilir Kalkınma

9. The role of ABO blood groups in glial neoplasia

Alkan A., Yazici G., Cengiz M., Celik I., Kars A., Zorlu F.

41st Annual Congress of the European-Society-for-Medical-Oncology (ESMO), Copenhagen, Danimarka, 7 - 11 Ekim 2016, cilt.27, (Özet Bildiri)

10. Using geographical information systems to describe quality of life as a function of distance in cancer patients

HAYRAN K. M., ERMAN M., KILIÇKAP S., DİZDAR Ö., YÜCE D., HÜSEYİN B., et al.

ISPOR Asia Pacific Meeting 2016, 3 - 06 Eylül 2016, cilt.19, ss.892, (Özet Bildiri)

11. Imaging the interactions between oral pathogens and probiotic lactic acid bacteria on the adhesion to human gingival fibroblast cells by confocal and fluorescein microscopy

Akca G., Celik I., Ermis M., Foto E.

41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.110-111, (Özet Bildiri)

12. ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN CHRONIC HEPATITIS B INFECTION PATIENTS IN TURKEY: A MULTICENTER STUDY

Karacaer Z., Cakir B., Erdem H., Ugurlu K., Durmus G., Ince N. K., et al.

EASL International Liver Congress, Barcelona, İspanya, 13 - 17 Nisan 2016, cilt.64, (Özet Bildiri) Sürdürülebilir Kalkınma

13. Prognostic factors for survival in patients with metastatic melanoma treated with ipilimumab: Turkish Oncology Group (TOG) Study

Urun Y., Abali H., Turna H., Esin E., Sedef A. M., Alkan A., et al.

European Cancer Congress, Vienna, Avusturya, 01 Ocak 2015, cilt.51, (Özet Bildiri)

14. The survival rate at 5 years in Turkish metastatic melanoma patients treated with ipilimumab: Final analysis of MIPI-TURK

Sevinc A., TURNA Z. H., Ozdogan M., Buyukberber S., Mandel N. M., Demir G., et al.

Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33, (Özet Bildiri)

15. Clinical experience with Vemurafenib in pretreated melanoma (MEL): The results of open label multi center study from Turkey

Celik I., Mandel N. M., Gokmen E., Unal O. U., Sevinc A., Coskun H. S., et al.

16. Multicentric ipilimumab experience in Turkish patients with metastatic melanoma: MIPI-TURK at 30 months of follow-up.

Sevinc A., TURNA Z. H., Ozdogan M., Buyukberber S., Demir G., Gokmen E., et al.

49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 31 Mayıs - 04 Haziran 2013, cilt.31, (Özet Bildiri)

Kitaplar 1

1. TÜTÜNSÜZ ÜNİVERSİTE İÇİN ADIM ADIM UYGULAMA REHBERİ

ESER Z., SÖZEN F., DEMİR E., DEMİRCİ DURAN H., CANBUL D., AKER S., et al.

BAŞKENT ÜNİVERSİTESİ, 2019

Metrikler

Yayın

110

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

1981

H-İndeks (WoS)

Atıf (Scholar)

4776

H-İndeks (Scholar)

Toplam Atıf Sayısı

2363

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler